Nutritional composition

US11464249B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11464249-B2
Application numberUS-201916406235-A
CountryUS
Kind codeB2
Filing dateMay 8, 2019
Priority dateJun 8, 2018
Publication dateOct 11, 2022
Grant dateOct 11, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Use of a lentil product to increase the bioavailability of non-haem iron in a composition comprising one or more anti-nutritional factors.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of maintaining or optimizing an iron status of an infant or child in need thereof, the method comprising administering to the infant or child a composition comprising non-haem iron, wholegrain, and a lentil product selected from the group consisting of a yellow lentil product, a red lentil product, and a combination thereof. 2. The method of claim 1 , wherein the composition is an infant cereal or a nutritional composition. 3. The method of claim 1 , wherein the non-haem iron is in the form of a physiologically acceptable iron chelate. 4. The method of claim 1 , wherein the lentil product is in the form of dehulled whole lentils, dehulled crushed lentils, dehulled lentil flour, and combinations thereof. 5. The method of claim 1 , wherein the composition comprises 5 to 70% of the lentil product. 6. The method of claim 1 , wherein the composition comprises 5 to 30% of the wholegrain. 7. The method of claim 1 , wherein the composition comprises 5 to 30% of the wholegrain, at least 1.6 mg/100 kcal of the non-haem iron, and 5 to 20% of the lentil product. 8. The method of claim 1 , wherein the wholegrain is selected from the group consisting of wholegrain maize, wheat, rice, oat, corn, barley, rye, semolina, and combinations thereof. 9. A method of increasing the-bioavailability of non-haem iron in a composition comprising non-haem iron, wholegrain, and an anti-nutritional factor, the method comprising adding to the composition a lentil product selected from the group consisting of a yellow lentil product, a red lentil product, and a combination thereof. 10. The method of claim 9 , wherein the anti-nutritional factor is phytic acid. 11. The method of claim 10 , wherein the phytic acid is selected from the group consisting of myo-inositol phosphate (lnsP), myo-inositol bisphosphate (lnsP2), myoinositol triphosphate (lnsP3), myo-inositol tetrakisphosphate (lnsP4), myo-inositol pentakisphosphate (lnsPS), myo-inositol hexakisphosphate (lnsP6), and combinations thereof. 12. The method of claim 9 , wherein the non-haem iron is in the form of a physiologically acceptable iron chelate. 13. The method of claim 9 , wherein the wholegrain is selected from the group consisting of whole grain maize, wheat, rice, oat, corn, barley, rye, semolina, and a combination of any of the foregoing. 14. The method of claim 9 , wherein the non-haem iron is selected from the group consisting of ferrous sulfate, ferrous bisglycinate, ferrous fumarate, and combinationa thereof. 15. The method of claim 9 , wherein the lentil product is in the form of dehulled whole lentils, dehulled crushed lentils, dehulled lentil flour, and combinations thereof. 16. A method of treatment or prevention of suboptimal iron levels in an infant or a child in need thereof, the method comprising administering to the infant or child a composition comprising non-haem iron, wholegrain, and a lentil product selected from the group consisting of a yellow lentil product, a red lentil product, and a combination thereof.

Assignees

Inventors

Classifications

  • Mashed or comminuted pulses or legumes; Products made therefrom (A23L11/30 takes precedence; tofu or soya cheese A23L11/45; soy drinks A23L11/65) · CPC title

  • Complexes or chelates · CPC title

  • Addition of substantially indigestible substances, e.g. dietary fibres · CPC title

  • Cereal-derived products · CPC title

  • Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11464249B2 cover?
Use of a lentil product to increase the bioavailability of non-haem iron in a composition comprising one or more anti-nutritional factors.
Who is the assignee on this patent?
Nestle Sa
What technology area does this patent fall under?
Primary CPC classification A23L11/01. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).